McCune-Albright-Braytsev syndrome: literature review and clinical case
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 1
Abstract
The paper presents the results of literature review on McCune-Albright-Braytsev syndrome and describes the clinical case of this syndrome. McCune-Albright-Braytsev syndrome is a genetically determined disease, usually characterized by a triad of symptoms: the presence of specific cafe-au-lait spots, fibrous dysplasia of the bones and various endocrinopathies, the most frequent of which is premature sexual development. The incidence of this disease in the world varies from 1 case per 100,000 to 1 case per million in the general population. McCune-Albright-Braytsev syndrome is caused by a mutation in GNAS1 gene. This gene encodes the alpha subunit of guanosine triphosphate binding protein (G protein), which stimulates the formation of cyclic adenosine monophosphate (cAMP) that, among other things, regulates the work of many endocrine glands in the body. The mutant protein constantly activates adenylate cyclase, the intracellular level of cAMP increases, which leads to spontaneous “inclusion” of hormone secretion. GNAS1 is on the long shoulder of chromosome 20. This cell mutation occurs in the early stages of embryogenesis. The described clinical case is of unquestionable interest in terms of somewhat delayed diagnosis of the syndrome, although pathological fractures are the classic signs of the disease. The success of the treatment of this disease directly depends on the early diagnosis and timely referral of the child to the appropriate endocrinological institution.
Authors and Affiliations
T. V. Sorokman, O. V. Makarova, N. О. Popeliuk
Keywords
Related Articles
- EP ID EP542585
- DOI 10.22141/2224-0721.15.1.2019.158696
- Views 63
- Downloads 0
New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus
This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin del...
Population Risk Factors in the Genesis of Bone Metabolism Didorders in Patients with Autoimmune Thyroiditis
The paper presents population risk factors involved in the genesis of bone metabolism disorders in patients with autoimmune thyroiditis (AIT). The results of the study of bone mineral density in patients with AIT are pro...
New guidelines of the American Diabetes Association 2018 on the diagnosis and treatment of diabetes mellitus
The article considers some aspects of the recently published recommendations of the American Diabetes Association on the diagnosis, prevention and treatment of diabetes mellitus.
Pathogenetic mechanisms and signs of cardiovascular disorders in type 2 diabetes mellitus
Background. A high morbidity and prevalence of diabetes mellitus (DM) cause early disability and mortality due to the development of chronic complications. The main cause of death in type 2 DM is associated with cardiova...
Hyperparathyroidism: Diagnosis, Clinical Signs and Symptoms, Modern Approaches to Treatment
.